DESJARDINS, CLARISSA,GROGAN, DONNA ROY,PACKMAN, JEFFREY NEAL,HARNETT, MARK
申请号：
CA3025854
公开号：
CA3025854A1
申请日:
2017.06.08
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The invention features dosing regimens and pharmaceutical formulations for oral administration of palovarotene. The dosing regimens can reduce heterotopic ossification, reduce the number of flare- ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
